£425.00

It has never been this cheap. We have no record of a lower price.

£425 today · cheaper than every other day in the last 3 months

Cancer Therapy Outlook 2016-2021 - North America & Caribbean

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 20 days · 20 data points (no recent data)

Historical
Generating forecast…
£425.00 £403.75 £412.25 £420.75 £429.25 £437.75 £446.25 03 August 2026 07 August 2026 12 August 2026 17 August 2026 22 August 2026
View at Amazon ↗

Price data last checked 71 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 20 days • 1 price levels

Days at Price
20 days 0 5 10 15 20 £425 Days at Price

Price Analysis

Most common price: £425 (20 days, 100.0%)

Price range: £425 - £425

Price levels: 1 different prices over 20 days

Description

This econometric study provides a detailed outlook for cancer therapies across North America and the Caribbean. Using advanced econometric models to project fundamental economic dynamics, the report calculates latent demand and potential industry earnings (P.I.E.) for each country in millions of U.S. dollars. Readers gain access to essential comparative benchmarks, including the percent share each country holds within the region and globally. These metrics allow for a quick assessment of individual country performance against others. This resource is designed for professionals needing data-driven insights into the economic landscape of the cancer therapy market during the 2016-2021 period.

Key Features

Provides annual estimates for latent demand and potential industry earnings (P.I.E.) in millions of U.S. dollars.

Includes comparative benchmarks showing each country's percent share of the region and the globe.

Utilizes econometric models to project fundamental economic dynamics within and across countries.

Covers the specific market outlook for cancer therapies in North America and the Caribbean from 2016-2021.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
21 May 2015
Listed Since
06 October 2015

Similar Products You Might Like

Cancer Therapies in Asia 2016-2021 Outlook - Econometric Study
99% match

Cancer Therapies in Asia 2016-2021 Outlook - Econometric Study

£425.00 22 Aug 2026
Cancer Therapies Outlook in Oceana 2016-2021 Econometric Study
99% match

Cancer Therapies Outlook in Oceana 2016-2021 Econometric Study

£425.00 25 Aug 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in China
98% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in China

£495.00 23 Sep 2026
The 2025-2030 World Outlook for Cancer Therapies
98% match

The 2025-2030 World Outlook for Cancer Therapies

Price unavailable
The 2023-2028 Outlook for Cancer Supportive Care Drugs in Japan
98% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in Japan

£495.00 02 Oct 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States
98% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States

£520.00 21 Aug 2026
The 2023-2028 Outlook for Cancer Supportive Care in the United States
98% match

The 2023-2028 Outlook for Cancer Supportive Care in the United States

£520.00 22 Aug 2026
The 2011-2016 Outlook for Non-Small Cell Lung Cancer Therapeutics in Africa, Europe & the Middle East
98% match

The 2011-2016 Outlook for Non-Small Cell Lung Cancer Therapeutics in Africa, Europe & the Middle East

£325.00 28 Oct 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in India
98% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in India

£515.00 21 Aug 2026
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Europe
98% match

The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Europe

£325.00 27 Sep 2026
NSCLC Therapeutics Outlook in Asia (2013-2018) Study
98% match

NSCLC Therapeutics Outlook in Asia (2013-2018) Study

£325.00 27 Aug 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in China
98% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in China

£495.00 01 Oct 2026
The 2023-2028 Outlook for Cancer Screenings in the United States
98% match

The 2023-2028 Outlook for Cancer Screenings in the United States

£520.00 20 Aug 2026
Hematology and Oncology Products Outlook 2016-2021 Report
98% match

Hematology and Oncology Products Outlook 2016-2021 Report

£425.00 20 Aug 2026
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Africa & the Middle East
98% match

The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Africa & the Middle East

£325.00 26 Sep 2026
The 2016-2021 World Outlook for Non-Small Cell Lung Cancer Therapeutics
97% match

The 2016-2021 World Outlook for Non-Small Cell Lung Cancer Therapeutics

£995.00 15 Aug 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in Japan
97% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in Japan

£495.00 26 Sep 2026
The 2021-2026 World Outlook for Silent Cancer Therapeutics
97% match

The 2021-2026 World Outlook for Silent Cancer Therapeutics

£795.00 31 Oct 2026
The 2023-2028 Outlook for Cancer Screenings in China
97% match

The 2023-2028 Outlook for Cancer Screenings in China

£495.00 29 Oct 2026
The 2023-2028 Outlook for Cancer Testing-Screening in the United States
97% match

The 2023-2028 Outlook for Cancer Testing-Screening in the United States

£520.00 30 Sep 2026
The 2025-2030 World Outlook for Cancer Specialty Hospitals
97% match

The 2025-2030 World Outlook for Cancer Specialty Hospitals

Price unavailable
The 2023-2028 Outlook for Cancer Testing-Screening in India
97% match

The 2023-2028 Outlook for Cancer Testing-Screening in India

£515.00 01 Oct 2026
The 2023-2028 Outlook for Cancer Screenings in Japan
97% match

The 2023-2028 Outlook for Cancer Screenings in Japan

£495.00 20 Aug 2026
The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in Japan
97% match

The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in Japan

£495.00 04 Sep 2026